Skip to Content »

Site Map

FREE Shipping: All Individuals in United States, Mexico, Central and South America & The Caribbean

Epilepsy Research

Epilepsy Research provides for publication of high quality articles in both experimental and clinical epilepsy research, with a special emphasis on translational research that ultimately relates to epilepsy as a human condition. The journal is intended to provide a forum for reporting the best and most rigorous epilepsy research from all disciplines ranging from biophysics and molecular biology to epidemiological and psychosocial research. As such the journal will publish original papers relevant to epilepsy from any scientific discipline and also studies of a multidisciplinary nature. Clinical and experimental research papers adopting fresh conceptual approaches to the study of epilepsy and its treatment are encouraged. The overriding criteria for publication are novelty, significant clinical or experimental relevance, and interest to a multidisciplinary audience in the broad arena of epilepsy. Review articles focused on any topic of epilepsy research will also be considered, but only if they present an exceptionally clear synthesis of current knowledge and future directions of a research area, based on a critical assessment of the available data or on hypotheses that are likely to stimulate more critical thinking and further advances in an area of epilepsy research.

Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.

Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: click here

View all Neurology titles

Impact Factor

* 2011 Journal Citation ReportsĀ®, published by Thomson Reuters

Customer Reviews

Epilepsy Research
  • Journal
  • Imprint: ELSEVIER
  • ISSN: 09201211
  • 2013 Impact Factor: 2.190*